Black Titan Corp (NASDAQ:BTTC – Get Free Report) was the target of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 77,733 shares, an increase of 3,138.9% from the June 15th total of 2,400 shares. Based on an average daily trading volume, of 905,542 shares, the short-interest ratio is currently 0.1 days. Currently, 1.6% of the shares of the company are short sold.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC bought a new position in shares of Black Titan during the 4th quarter valued at approximately $26,000. HRT Financial LP bought a new stake in Black Titan during the 4th quarter worth approximately $28,000. Marex Group plc purchased a new position in Black Titan during the fourth quarter valued at approximately $84,000. Finally, Armistice Capital LLC purchased a new position in Black Titan during the fourth quarter valued at approximately $840,000.
Black Titan Stock Performance
Shares of Black Titan stock traded down $0.05 on Friday, hitting $0.76. 15,047 shares of the company’s stock were exchanged, compared to its average volume of 481,150. Black Titan has a 1 year low of $0.68 and a 1 year high of $39.00. The firm has a 50-day moving average of $0.97. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.62 and a quick ratio of 4.62. The company has a market capitalization of $8.14 million, a PE ratio of -0.26 and a beta of 1.21.
Black Titan Company Profile
Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
Featured Stories
- Five stocks we like better than Black Titan
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.
